AP 151 (Guaifenesin 200 mg)
Pill imprint AP 151 has been identified as Guaifenesin 200 mg.
Guaifenesin is used in the treatment of bronchitis; fibromyalgia; cough; bronchiectasis and belongs to the drug class expectorants. Risk cannot be ruled out during pregnancy. Guaifenesin 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about guaifenesin
- Guaifenesin granules
- Guaifenesin immediate-release capsules
- Guaifenesin liquid
- Guaifenesin sustained-release tablets
- Guaifenesin (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.